Table 1.
Clinical and demographic characteristics of children in the 3 months of weekly rifapentine and isoniazid for tuberculosis preventive treatment (N = 26).
Fig 1.
Dose of anti-tuberculosis per kilogram of body weight (24 children).
Table 2.
Treatment outcomes and adverse drug reactions during 3 months of weekly rifapentine and isoniazid for tuberculosis preventive treatment (N = 26).